Shingrix presents a new paradigm for shingles prevention
By Eo, Yun-Ho | translator Choi HeeYoung
22.12.15 15:15:46
°¡³ª´Ù¶ó
0
GSK Korea holds a meeting to commemorate its launch
Clinical demonstration of herpes zoster prevention efficacy
¡ã Professor Yoon
Korea GSK's herpes zoster vaccine "Shingrix" announced its official launch. GSK held a press conference at InterContinental Seoul COEX on the 15th to commemorate the launch of Shingrix, a shingles-prevention vaccine, in Korea. At the meeting, Yoon Kyung-young, an infectious medicine professor at Korea University Anam Hospital, introduced the epidemiology of shingles, the risk of diseases and complications, and strategies to prevent shingles through unmet needs and vaccines.Shingles occur when the varicella-zoster virus, a chickenpox-causing virus, is reactivated. Shingles are accompanied by unbearable pain, and some patients may experience neuralgia (post-shingles neuralgia) that lasts for months to ye
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)